Johnson & Johnson won’t set aside any legal reserves for the more than 100,000 lawsuits it faces across its portfolio of drugs, consumer products and medical devices, saying it expects to fight and win many of the claims. The company …
Purdue Pharma LP and its billionaire owners won a temporary reprieve from nearly 2,700 opioid lawsuits, giving the bankrupt drugmaker time to clinch a deal that would atone for its role in America’s addiction epidemic. U.S. Bankruptcy Judge Robert D. …
Purdue Pharma LP’s billionaire owners, the Sackler family, are a step closer to a trial in Massachusetts over their role in the opioid epidemic, after a judge said the state had made credible allegations of misconduct in marketing of the …
The public cost of coping with the opioid crisis in the U.S. “dwarfs” the combined resources of the companies sued for allegedly causing the epidemic, including OxyContin maker Purdue Pharma LP, a lawyer for New York State told a judge. …
The last scheduled trial of the year over Bayer AG’s Roundup herbicide has been postponed at the request of both parties, indicating that talks toward a settlement may be progressing. The delay to the trial in St. Louis, following two …
The first big fight in Purdue Pharma LP’s bankruptcy case is taking shape as states and cities across the U.S. challenge a request by the drug maker and its billionaire owners, the Sackler family, for an injunction to block lawsuits …
Johnson & Johnson agreed to pay more than $20 million to avoid the first federal trial in which it faced accusations of helping fuel the opioid epidemic by mishandling its painkillers. Under the deal, announced late Tuesday, J&J will pay …
ALBANY, N.Y. — He was accused of calling his female co-workers “whores,” grabbing one woman’s head and forcing it between his legs, threatening another with sexual assault and exposing himself in the office. Now, more than a year after he …
The Cleveland judge overseeing more than 2,000 federal lawsuits over alleged opioid abuses refused to disqualify himself from a bellwether trial set to start next month, rejecting a request by drug distributors and pharmacies who say he is biased against …
Purdue Pharma LP’s deal to escape thousands of lawsuits over its role in the U.S. opioid crisis may provide less than half the $10 billion that the closely held drugmaker projected in its Chapter 11 filing, said three people familiar …